Our study revealed that tumors with the high mutation signature exhibited considerably more intratumoral infiltration of CD8 T cells (Fig. 7B), NK cells (Fig. 7C), and B cells (Fig. 7E) in the NSCLC patients from TCGA pan cancer atlas cohort. The gene discussed is CD8A; the disease is cancer.